Correction: Hamilton et al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305

By sjmartinez • March 12, 2024

Hamilton N, Austin D, Márquez-Garbán D, Sanchez R, Chau B, Foos K, Wu Y, Vadgama J, Pietras R. Correction: Hamilton et al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305. Int J Mol Sci. 2024 Feb 23;25(5):2579. doi: 10.3390/ijms25052579. Erratum for: Int J Mol Sci. 2017 Nov 02;18(11): PMID: 38474325.

Tags: Endocrinology, General Internal Medicine, Hematology/Oncology, King Drew Med Ctr, Publications

Workshop Report-Heterogeneity and Successful Aging Part I: Heterogeneity in Aging-Challenges and Opportunities

Kuchel GA, Hevener AL, Ruby JG, Sebastiani P, Kumar V. Workshop Report-Heterogeneity and Successful Aging Part I: Heterogeneity in Aging-Challenges and Opportunities. J Gerontol A[...]

Identification of Wnt-5a Receptors Important in Diabetic and Non-Diabetic Corneal Epithelial Wound Healing

Shah R, Amador C, Poe AJ, Spektor TM, Bhandary P, Wang Y, Wang ZP, Weisenberger DJ, Borges VF, Sawant OB, Maguen E, Hamrah P, Kramerov[...]

Glycemic Control in Patients with Employer-Sponsored Health Benefits

Louie JZ, Rowland CM, Shiffman D, Garg R, Bernal-Mizrachi E, McPhaul MJ. Glycemic Control in Patients with Employer-Sponsored Health Benefits. Popul Health Manag. 2025 Feb;28(1):8-14.[...]